Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

Basit Öğe Kaydı
dc.authorscopusid6507644797
dc.authorscopusid8883590100
dc.authorscopusid47661749700
dc.authorscopusid35602089900
dc.authorscopusid55382765700
dc.authorscopusid36338358200
dc.authorscopusid55358621700
dc.contributor.authorHemmelder M.H.
dc.contributor.authorNoordzij M.
dc.contributor.authorVart P.
dc.contributor.authorHilbrands L.B.
dc.contributor.authorJager K.J.
dc.contributor.authorAbrahams A.C.
dc.contributor.authorArroyo D.
dc.date.accessioned2024-08-04T19:59:34Z
dc.date.available2024-08-04T19:59:34Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground. Coronavirus disease 2019 (COVID-19)-related short-term mortality is high in dialysis patients, but longer-term outcomes are largely unknown. We therefore assessed patient recovery in a large cohort of dialysis patients 3 months after their COVID-19 diagnosis. Methods. We analyzed data on dialysis patients diagnosed with COVID-19 from 1 February 2020 to 31 March 2021 from the European Renal Association COVID-19 Database (ERACODA). The outcomes studied were patient survival, residence and functional and mental health status (estimated by their treating physician) 3 months after COVID-19 diagnosis. Complete follow-up data were available for 854 surviving patients. Patient characteristics associated with recovery were analyzed using logistic regression. Results. In 2449 hemodialysis patients (mean ± SD age 67.5 ± 14.4 years, 62% male), survival probabilities at 3 months after COVID-19 diagnosis were 90% for nonhospitalized patients (n = 1087), 73% for patients admitted to the hospital but not to an intensive care unit (ICU) (n = 1165) and 40% for those admitted to an ICU (n = 197). Patient survival hardly decreased between 28 days and 3 months after COVID-19 diagnosis. At 3 months, 87% functioned at their pre-existent functional and 94% at their pre-existent mental level. Only few of the surviving patients were still admitted to the hospital (0.8–6.3%) or a nursing home (?5%). A higher age and frailty score at presentation and ICU admission were associated with worse functional outcome. Conclusions. Mortality between 28 days and 3 months after COVID-19 diagnosis was low and the majority of patients who survived COVID-19 recovered to their pre-existent functional and mental health level at 3 months after diagnosis. © The Author(s) 2022.en_US
dc.identifier.doi10.1093/ndt/gfac008
dc.identifier.endpage1151en_US
dc.identifier.issn0931-0509
dc.identifier.issue6en_US
dc.identifier.pmid35030246en_US
dc.identifier.scopus2-s2.0-85129660616en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1140en_US
dc.identifier.urihttps://doi.org/10.1093/ndt/gfac008
dc.identifier.urihttps://hdl.handle.net/11616/90728
dc.identifier.volume37en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofNephrology Dialysis Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectdialysisen_US
dc.subjectfunctional health statusen_US
dc.subjectmental health statusen_US
dc.subjectsurvivalen_US
dc.titleRecovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODAen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu